{
  "job_id": "79fa233e-4ec0-4b7a-9f5c-8516231182ba",
  "payload": {
    "text": "PROTOCOL TITLE: A Phase 2, Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of Experimental Drug X in Patients with Advanced Non-Small Cell Lung Cancer. Side effects will be assessed using CTCAE version 4.0. Serious adverse events must be reported within 24 hours. Regular monitoring will include complete blood count, comprehensive metabolic panel, and liver function tests.",
    "ta": "oncology",
    "user_id_hash": null,
    "chunked": false
  },
  "status": "queued",
  "created_at": "2025-11-09T16:37:17.030279",
  "chunked": false,
  "chunk_count": 0
}